Effective immunosuppressive therapy in a patient with primary pulmonary hypertension

Thorax

Volumn 54, Issue 4, 1999, Pages 372-374

  Bellotto, F ^b   Chiavacci, P ^b   Laveder, F ^b   Angelini, A ^b   Thiene, G ^b   Marcolongo, R ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b NONE

Author keywords

Methotrexate; Pulmonary hypertension; Transforming growth factor

Indexed keywords

METHOTREXATE; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LUNG ARTERY PRESSURE; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

EID: 0032986928     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.54.4.372     Document Type: Article

References (13)

1. 1 Rubin LJ. Primary pulmonary hypertension. N Engl J Med 1997;336:111-17.
2. 2 Doll NJ, Salvaggio JE. Pulmonary manifestation of collagen vascular disease. Semin Respir Med 1984;5:273-81.
3. 3 D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991;115: 343-9.
4. 4 Bjornsson J, Edwards WD. Primary pulmonary hypertension: a histopathologic study of 80 cases. Mayo Clin Proc 1985;60:16-25.
5. 5 Rozkovec A, Montanes P, Oakley CM. Factors that influence the outcome of primary pulmonary hypertension. Br Heart J 1986;55:449-58.
6. 6 Tuder RM, Groves B, Badesch DB, et al. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesion of pulmonary hypertension. Am J Pathol 1994;144:275-85.
7. 7 Humbert M, Monti G, Brenot F, et al. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med 1995;151:1628-31.
8. 8 Voelkel NF, Tuder RM. Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension. Eur Respir J 1995;8:2129-38.
9. 9 Scott PH, Peacock AJ. Cell signalling in pulmonary vascular cells: do not shoot the messenger! Thorax 1996;51:864-6.
10. 10 Goupille P, Fauchier L, Babuty B, et al. Precapillary pulmonary hypertension dramatically improved with high doses of corticosteroids during SLE. J Rheumatol 1994;21:1976-7.
11. 11 Morelli S, Giordano M, De Marzio P, et al. Pulmonary arterial hypertension responsive to immunosuppressive therapy in SLE. Lupus 1993;2:367-9.
12. 12 Dahl M, Chalmers A, Wade J, et al. Ten year survival of a patient with advanced pulmonary hypertension and MCTD treated with immunosuppressive therapy. J Rheumatol 1992;19:1807-9.
13. 13 Morse JH, Barst RJ, Fotino M, et al. Primary pulmonary hypertension: immunogenetic response to high-mobility group (HMG) proteins and histone. Clin Exp Immunol 1996;106:389-95.